| Sub Cat | Immunogen | Isotype | Application | Affinity | |
|---|---|---|---|---|---|
| V3S-1124-YC345 | IgG4 kappa | ELISA; IHC; FC; IP; IF; Inhib | |||
| V3S-0522-YC3198 | Human CD40-expressing mouse EL-4 cells | IgG2 kappa | ELISA; FC; Neut | ||
| V3S-0522-YC3199 | Human CD40-expressing mouse EL-4 cells | IgG1 kappa | ELISA; FC; Neut | ||
| V3S-0622-YC1330 | IgG1 kappa | FuncS | |||
| V3S-0622-YC1331 | IgG | FuncS | |||
| V3S-0622-YC3039 | CD40-expressing EL-4 cells | IgG | Neut; ELISA | ||
| V3S-0622-YC4335 | IgG | ELISA; FC; IP; FuncS; IF; Neut; IHC | |||
| V3S-0522-YC1495 | IgG2 kappa | ELISA; IHC; FC; IP; IF; FuncS | |||
| V3S-0522-YC3197 | A human B cell tumor line: Ramos, HS Sultan or IM-9 cells | IgG | FC; FuncS | ||
| V3S-0522-YC5312 | IgG1 kappa | ELISA | |||
| V3S-0622-YC3018 | IgG1 lambda | ELISA | 20 pM | ||
| V3S-0622-YC3022 | IgG | ELISA; WB | 10 pM | ||
| V3S-0622-YC3023 | IgG | ELISA | 11 pM | ||
| V3S-0622-YC3024 | IgG | ELISA | 72 pM | ||
| V3S-0622-YC3025 | IgG | ELISA; IHC | |||
| V3S-0622-YC3026 | IgG | ELISA; WB | 30 pM | ||
| V3S-0622-YC3027 | IgG | ELISA; WB | 43 pM | ||
| V3S-0622-YC3028 | IgG | ELISA; WB; IP | 45 pM | ||
| V3S-0622-YC3029 | IgG | ELISA | 14 pM | ||
| V3S-0622-YC3036 | IgG1 | ELISA; IHC | |||
| V3S-0622-YC3042 | IgG kappa | IHC; IF | |||
| V3S-0622-YC3043 | IgG kappa | ELISA | |||
| V3S-0622-YC3044 | IgG kappa | ELISA; IHC | |||
| V3S-0622-YC3045 | IgG kappa | ELISA; FC | |||
| V3S-1022-YC2604 | IgG | ELISA | |||
| V3S-1022-YC277 | IgG1 | Activ; IF | |||
| V3S-1022-YC597 | IgG | ELISA | |||
| V3S-1222-YC594 | IgG4 | ELISA; WB | |||
| V3S-0622-YC82 | IgG1 kappa | FuncS |
| Description | This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Tumor necrosis factor receptor superfamily member 5. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Isotype | IgG4, κ |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | ELISA; IHC; FC; IP; IF; Inhib |
| Application Notes | The antibody is recommended for detection of CD40 by ELISA, IHC, FC, IP, IF, Inhib assays. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
